<?xml version="1.0" encoding="UTF-8"?>
<document id="30264546">
	<sentence id="s1" text="However, in hepatocellular carcinoma (HCC), the characteristics and mechanism of IDO1 expression have not been well defined.">
		<entity id="s1.e1" charOffset="12-36"
			type="HP" text="hepatocellular carcinoma" ontology_id="HP_0001402"/>
		<entity id="s1.e2" charOffset="38-41"
			type="GENE" text="HCC" ontology_id="84668"/>
		<entity id="s1.e3" charOffset="81-85"
			type="GENE" text="IDO1" ontology_id="3620"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="In this study, IDO1 expression in tumor cells (T-IDO1) was frequently detected (109/112) by immunohistochemistry in formalin-fixed paraffin-embedded specimens from HCC patients, and the expression patterns were mostly focal (102/109).">
		<entity id="s2.e1" charOffset="15-19"
			type="GENE" text="IDO1" ontology_id="3620"/>
		<entity id="s2.e2" charOffset="34-39"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s2.e3" charOffset="164-167"
			type="GENE" text="HCC" ontology_id="84668"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e3" pgr="false"/>
	</sentence>
	<sentence id="s3" text="These findings indicated that T-IDO1 expression in HCC is common and is dominantly driven by the host antitumor immune response, which is a favorable prognostic factor in HCC">
		<entity id="s3.e1" charOffset="32-36"
			type="GENE" text="IDO1" ontology_id="3620"/>
		<entity id="s3.e2" charOffset="51-54"
			type="GENE" text="HCC" ontology_id="84668"/>
		<entity id="s3.e3" charOffset="106-111"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e3" pgr="false"/>
		<pair id="s3.p2" e1="s3.e2"
		    e2="s3.e3" pgr="false"/>
	</sentence>
</document>
